Transcranial Doppler Devices Market Growth, Trends, Absolute Opportunity and Value Chain 2017-2027

TOPICS:

Posted By: hussain May 2, 2017

Hematology word comes from Greek ‘haima’ and ‘logos’ meaning blood and discourse respectively. Hematology encompasses the science or study of blood cells and coagulation. Blood being the only fluid that flows throughout the human body, analysis of blood sample is essential for detection of common physiological indications such as anaemia, infections, diabetes, autoimmune disorders and cancer. Blood analysis or testing also exposes genetic information, viruses, organ deficiencies, etc. Hematology analyzers commercially available for analysis of blood and blood related disorders can take form of simple handheld photo-optical devices, sophisticated diagnostic point-of-care instruments and highly automated or complex laboratory analyzer. Complexity of the instrument varies with type of test, level of automation and requirement of computer connectivity. Hematology analyzers basically differ from each other in sample throughput rate as well as in total number of blood parameters analysed or measured. Hematology analyzers is used to carry out common blood tests such as complete blood count (CBC), blood chemistry tests, blood enzyme tests and other tests that measure cholesterol and triglycerides to aid in assessment of presence or risk of heart disease. The most common test amongst all is complete blood count (CBC) wherein, various components of blood are counted such as, red blood cells (RBC’s), white blood cells (WBC’s), platelets, haemoglobin and haematocrit.

Hematology analyzers work on coulter principle, VCS (Volume, Conductivity and Scatter) technology as well as hydrodynamic focussing. Currently available hematology sensors use combination of light absorption, light scatter, fluorescence, electrical impedance and conductivity. Hematology analyzers contains basic mechanical parts namely, pumps, syringes, tubing and motors who work in conjunction with reagents, optics and software to provide appropriate results of tests to clinicians. Reagents used in the Hematology analyzers are solutions that are used either in dilution of the blood being tested or to differentiate and mark various blood components that further enables electrical and optical analysis.

Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-3359 

Hematology Analyzer and Reagents Market: Drivers and Restraint

Automated analyzers, point-of-care diagnostic analyzers and handheld photo-optic devices have become complex and high-tech along with user-friendly and easy in operation, driving the market for hematology analyzer and reagent market. Laboratories select hematology analyzers and reagents on basis of patient population, reliability, service, precision, accuracy budgetary constraints, current and anticipated scope of laboratory services, etc. Manufacturers has overseen and researched these requirements in order to target specific analyzers to varied number of laboratories and has thus brought prosperity to hematology analyzers and reagents market. For example, traditional bench top optical hematology analyzers measured up to 50-60 centimetres in length and 10 centimetres in diameter and was too expensive while today due to drive towards miniaturization the same analyzers is 10-15 centimetres long and 3 centimetres in diameter.  Blood testing required for large number of blood and blood-related disorders is also a major driver in hematology analyzers and reagents market.

One of the restraint in hematology analyzers and reagents market is high cost of the instrument and low adoption of advanced hematology analyzers and reagents in emerging and under developed countries. While other restraints include product recall and fierce competition amongst the manufacturers posing pressure for cost reduction

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-3359 

Hematology Analyzer and Reagents Market: Segmentation

The global hematology analyzer and reagents market is classified on the basis of product type, distribution channel and geography.

Based on product type, the global hematology analyzer and reagents market is segmented into the following:

  • Handheld Photo-Optic Devices
  • Point-Of-Care Diagnostic Analyzer
  • Automated Blood Analyzer
  • Consumables
    • Reagents
    • Stains
    • Calibrators and Controls

Based on end users, the global hematology analyzer and reagents market is segmented into the following:

  • Hospitals
  • Specialized Diagnostic Centers
  • Specialized Research Institutes
  • Others

Hematology Analyzer and Reagents Market: Overview

Development of precise, flexible and user-friendly technologies that are cost-effective has been a trend in hematology analyzers and reagent.Advancement in research has led to more professional demands and capabilities in units of testing. Speed-to-market and competitive cost have been one of the primary drivers in the development of hematology analyzers and reagents market.

Hematology Analyzer and Reagents Market: Regional Overview

The Hematology Analyzer and Reagents market is classified on basis of regions into, North America, Latin America, Eastern Europe, Western Europe, APEJ, Japan and MEA. North America is the largest market for Hematology Analyzer and Reagents due to easy adoption of highly advanced laboratory analyzers. While hematology analyzers and reagent market has seen a steady increase and has potential to prosper in countries like Japan, China, India, etc. Development in healthcare facilities, increasing prevalence in blood and blood related disorders such as cancer, growing health awareness among population, increase in number of highly advanced diagnostic clinics and many such factors contribute to increase in hematology analyzer and reagents market in emerging nations.

Browse Full Report@ http://www.futuremarketinsights.com/reports/hematology-analyzer-and-reagents-market 

Hematology Analyzer and Reagents Market: Key Players

Some of the key players in Hematology Analyzer and Reagents market include Abbott, Siemens AG, Beckman Coulter Inc, HORIBA, Ltd, Sysmex Corporation, Abaxis, Hoffmann-La Roche Ltd and others.

Transcranial Doppler Devices Market Growth, Trends, Absolute Opportunity and Value Chain 2017-2027

TOPICS:

Posted By: hussain May 2, 2017

Transcranial Doppler is an examination technique uses to measure brain’s blood flow velocity from the basal intracerebral vessels by measuring echoes produced from ultrasound waves which are moving transcranially.A low-frequency transducer nearly of 2 MHz is used to enable sufficient transmission of ultrasound waves through the skull. Transcranial Doppler has an excellent diagnosis accuracies.

Transcranial Doppler is relatively quick and detects arteriovenous malformations, ischemic cerebrovascular disease, sickle cell and cerebral circulatory arrest. Its non-invasive nature and high temporal resolution make it supreme for the study of cerebral hemodynamics. The developed Transcranial Doppler system is an exclusive combination of the certified medical device and research equipment. Technical advancement has led the quick development of portable devices , due to chip integrated circuits containing fast, integrated and low power systems. The impact of such improvements in reforming the global healthcare sector is also recognized as a fundamental factor driving the demand for Transcranial Doppler systems.

Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-3358

Transcranial Doppler Market: Drivers and Restraints

Variability in age, hematocrit, gender, increase in blood pressure and mental or motor activity disorders, rising awareness of neurodegenerative diseases among a population and has therapeutic potential are the primary drivers for Transcranial Doppler market. Its unique design allows the implementation of the advanced signal processing while keeping the costs low. Transcranial Doppler also used in combination with CT scan, MRI, MRA and carotid duplex ultrasound. Transcranial Doppler technology allows help clinician to gain knowledge about concerned flow characteristics within the insonated vessel and helps in rapid decision making. Poor reimbursement policies and lack of trained professionals are the main challenges for transcranial Doppler market.Systems only built for adults because of the design in which head size is fixed to a narrow range of circumferences excluding to perform check on infants and small children due to their small head size.

ABC Market: Segmentation

The global market for Transcranial Doppler systems is segmented by product type, display mode, and end users

By Display Mode

M-mode display

B-mode display

By Modality

Portable

Standalone

By End-users[G28]

Hospitals

Specialty clinics

Surgical centers

B-mode Transcranial color-coded duplex (TCCD) combines pulsed wave Doppler ultrasound identifies the arteries abo utvarious anatomic locations with a cross-sectional view of the area of insonation. M-mode display, more advanced technology provides multi-gate flow information and recently Transcranial Doppler market is based on this new technology.

Transcranial Doppler market segmentation on end users including hospitals, clinics, and surgical centers use it for diagnosis of acute ischemic stroke, intracranial steno-occlusive disease, collateral flow, sickle cell disease, micro- emboli detection and some cerebrovascular diseases.

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-3358

Transcranial Doppler Market: Overview

Strategic collaborations between manufacturers, suppliers and end users and is expected to boost revenue growth of the transcranial Doppler devices market over the forecast period. Transcranial Doppler is aninvaan invasiveique which is the most preferred tool across the majority of clinical uses and the assumptions made about vessel diameter on Transcranial Doppler. According to WHO report, approximately 6.8 million people die every year because of neurological disorder. In the U.S each year more than 1 million athlete experience concussion, according to an AAN press release. Transcranial Doppler is an advanced form of ultrasound may provide a more accurate diagnosis of concussion.

Transcranial Doppler Market: Region-wise Outlook

North America market of Transcranial Doppler dominates the market of other regions. Geography and application classify North America transcranial Doppler market. The primary application of North AmericaTranscranial Doppler market is the diagnosis of sickle cell anemia, emboli detection, and intracranial stenosis.

European and North America region comprises of a vast number of aging population which increases the risk of mental or brain disorders are the primary drivers for the increase in transcranial Doppler market. As per WHO report the economic cost of the neurological disorder in Europe was estimated at 139 million euros, in 2004. In Asia, because of diverse environmental conditions as well as changing lifestyle have led to brain diseases among adults as well as geriatric population. This has created high demand for brain monitoring devices for rapid diagnosis increasing the TCD market. In addition to these factors, government and nongovernment players are investing the huge amount in health care sector.

Transcranial Doppler Market: Key Market Participants

Some of the major companies that have contributed towards this market are Cadwell Laboratories , Inc., Natus Medical, Inc., Life Sciences, Spiegelberg GmbH & Co. KG, Covidien, Elekta, Rimed Ltd., andAtys Medical.

Browse Full Report@ http://www.futuremarketinsights.com/reports/transcranial-doppler-devices-market